EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Ribosome biogenesis and ribosomal proteins in cancer stem cells: a new therapeutic prospect

Priya Samanta, Rituparna Ghosh, Shampa Pakhira, Mrinmoyee Mondal, Souradeep Biswas, Rupali Sarkar, Arijit Bhowmik, Prosenjit Saha, Subhadip Hajra

Molecular Biology Reports · 2024

DOI: 10.1007/s11033-024-09963-y ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Biology Reports, 2024. Verfasst von Priya Samanta und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cancer Chemoprevention, Chittaranjan National Cancer Institute (CNCI), 37, S.P. Mukherjee Road, Kolkata, West Bengal, 700026, India. Hauptthemen laut MEDLINE: Neoplastic Stem Cells, Ribosomes, Ribosomal Proteins, Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 103 Literaturangaben. Gefördert von: Indian Council of Medical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ribosome has been considered as the fundamental macromolecular machine involved in protein synthesis in both prokaryotic and eukaryotic cells. This protein synthesis machinery consists of several rRNAs and numerous proteins. All of these factors are synthesized, translocated and assembled in a tightly regulated process known as ribosome biogenesis. Any impairment in this process causes development of several diseases like cancer. According to growing evidences, cancer cells display alteration of several ribosomal proteins. Besides, most of them are considered as key molecules involved in ribosome biogenesis, suggesting a correlation between those proteins and formation of ribosomes. Albeit, defective ribosome biogenesis in several cancers has gained prime importance, regulation of this process in cancer stem cells (CSCs) are still unrecognized. In this article, we aim to summarize the alteration of ribosome biogenesis and ribosomal proteins in CSCs. Moreover, we want to highlight the relation of ribosome biogenesis with hypoxia and drug resistance in CSCs based on the existing evidences. Lastly, this review wants to pay attention about the promising anti-cancer drugs which have potential to inhibit ribosome biogenesis in cancer cells as well as CSCs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplastic Stem CellsRibosomesRibosomal ProteinsNeoplasmsHumansAntineoplastic AgentsAnimalsDrug Resistance, NeoplasmProtein Biosynthesis

Stichwörter der Autor:innen

Cancer stem cellExtra ribosomal functionRibosomal proteinRibosome biogenesisTherapeutic agents

Substanzen

Ribosomal ProteinsAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Cancer Chemoprevention, Chittaranjan National Cancer Institute (CNCI), 37, S.P. Mukherjee Road, Kolkata, West Bengal, 700026, India.
  • Department of Cancer Chemoprevention, Chittaranjan National Cancer Institute (CNCI), 37, S.P. Mukherjee Road, Kolkata, West Bengal, 700026, India. subhadiphajra@cnci.ac.in.

Förderung

  • Indian Council of Medical Research

Zitieren

APA

Samanta, P., Ghosh, R., Pakhira, S., Mondal, M., Biswas, S., Sarkar, R., Bhowmik, A., Saha, P., & Hajra, S. (2024). Ribosome biogenesis and ribosomal proteins in cancer stem cells: a new therapeutic prospect. Molecular Biology Reports. https://doi.org/10.1007/s11033-024-09963-y

Vancouver

Samanta P, Ghosh R, Pakhira S, Mondal M, Biswas S, Sarkar R, et al. Ribosome biogenesis and ribosomal proteins in cancer stem cells: a new therapeutic prospect. Molecular Biology Reports. 2024. doi:10.1007/s11033-024-09963-y

BibTeX
@article{Samanta2024,
  author = {Samanta, Priya and Ghosh, Rituparna and Pakhira, Shampa and Mondal, Mrinmoyee and Biswas, Souradeep and Sarkar, Rupali and Bhowmik, Arijit and Saha, Prosenjit and Hajra, Subhadip},
  title = {Ribosome biogenesis and ribosomal proteins in cancer stem cells: a new therapeutic prospect},
  journal = {Molecular Biology Reports},
  year = {2024},
  doi = {10.1007/s11033-024-09963-y}
}
Kostenlos starten →